Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human diseases.

Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.

For partnering enquiries, please contact us at [email protected]. Alternatively, you can meet us at the following upcoming conferences:

Grants & Awards

Our awards include the following